SuperNova Dx Inks China Collaboration with KSB Diagnostics | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – SuperNova Diagnostics today said that it has signed a collaboration agreement with Shenzhen Kang Bao Bio-Technology.

The Germantown, Md.-based startup did not say what functions KSB Diagnostics will be performing on its behalf, but noted that the Hong Kong firm specializes in the research, manufacture, and distribution of in vitro diagnostic kits and research reagents in China and other markets in the area.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."